| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Ordinary Shares, $0.0001 par value |
| (b) | Name of Issuer:
Bioceres Crop Solutions Corp. |
| (c) | Address of Issuer's Principal Executive Offices:
PO BOX 309, UGLAND HOUSE, GEORGE TOWN, GRAND CAYMAN,
CAYMAN ISLANDS
, KY1-1104. |
| Item 2. | Identity and Background |
|
| (a) | This Amendment No. 1 to Schedule 13D (this "Schedule 13D") is filed by Agriculture Investment Group Corp. ("AIGC") and Granosur Holding Limited ("Granosur", and collectively, the "Reporting Persons"). |
| (b) | The principal business address of each of the Reporting Persons is Craigmuir Chambers, Road Town, Tortola, British Virgin Islands, VG1110. |
| (c) | AIGC is an agricultural company primarily dedicated to leasing land for livestock, rice, dryland farming, and forestry, as well as to its own agricultural production. AIGC conducts its trading activities through Granosur. |
| (d) | During the past five years, none of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). |
| (e) | During the past five years, none of the Reporting Persons have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding the Reporting Person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| (f) | AIGC is a company incorporated under the laws of the British Virgin Islands.
Granosur is a company incorporated under the laws of the British Virgin Islands. |
| Item 3. | Source and Amount of Funds or Other Consideration |
| | This Schedule 13D is being filed to report an decrease in the number of Ordinary Shares, $0.0001 par value of Bioceres Crop Solutions Corp. (the "Shares") beneficially owned by the Reporting Persons, as a result of the sale of Shares (the "Transaction"). In connection with the Transaction, AIGC sold an aggregate of 908,274 Shares. As a result of the foregoing, the number of Shares beneficially owned by the Reporting Persons decreased to 9,786,395. |
| Item 4. | Purpose of Transaction |
| | Except as described in Item 4 to this Schedule 13D, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, although, subject to the agreements described herein, the Reporting Persons, at any time and from time to time, may review, reconsider and change their position and/or change their purpose and/or develop such plans. Although the foregoing reflects plans and proposals presently contemplated by each Reporting Person with respect to the Issuer, the foregoing is subject to change at any time and is dependent upon contingencies and assumed and speculative conditions, and there can be no assurance that any of the actions set forth above will be taken. |
| Item 5. | Interest in Securities of the Issuer |
| (a) | See responses above to Items 11 and 13 for each of AIGC and Granosur. |
| (b) | See responses above to Items 7, 8, 9, and 10 for each of AIGC and Granosur. |
| (c) | On January 23, 2026, AIGC sold 55,703 Shares of the Issuer in open market transactions at an average sale price of $1.22 for aggregate gross proceeds of $68,097.
On January 26, 2026, AIGC sold 92,661 Shares of the Issuer in open market transactions at an average sale price of $1.23 for aggregate gross proceeds of $113,857.
On January 27, 2026, AIGC sold 72,478 Shares of the Issuer in open market transactions at an average sale price of $1.17 for aggregate gross proceeds of $84,963.
On January 28, 2026, AIGC sold 38,062 Shares of the Issuer in open market transactions at an average sale price of $1.11 for aggregate gross proceeds of $42,376.
On January 29, 2026, AIGC sold 109,516 Shares of the Issuer in open market transactions at an average sale price of $1.02 for aggregate gross proceeds of $111,870.
On January 30, 2026, AIGC sold 200,000 Shares of the Issuer in open market transactions at an average sale price of $0.88 for aggregate gross proceeds of $175,744.
On February 3, 2026, AIGC sold 132,414 Shares of the Issuer in open market transactions at an average sale price of $0.60 for aggregate gross proceeds of $79,991.
On February 4, 2026, AIGC sold 207,440 Shares of the Issuer in open market transactions at an average sale price of $0.62 for aggregate gross proceeds of $128,841.
Except as disclosed in this Schedule 13D, no transactions in the Shares or securities convertible into, exercisable for, or exchangeable for Shares were effected during the past sixty days by the Reporting Persons. |
| (d) | Except as otherwise described in this Item 5, no one other than the Reporting Persons has the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, any of the Shares beneficially owned by the Reporting Persons as described in this Item 5. |
| (e) | N/A |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
| | To the best of the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons or between the Reporting Persons and any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. |
| Item 7. | Material to be Filed as Exhibits. |
| | Exhibit 99.1 Joint Filing Agreement |
